In elderly individuals with a prior heart attack, daily consumption of 25 mL of high-phenolic extra virgin olive oil for 26 weeks increases serum antioxidant capacity by 67.7 μM Fe²⁺ and paraoxonase-1 activity by 3.68 U/mL compared to baseline levels.
See the scientific wording
Consuming 25 mL per day of high-phenolic extra virgin olive oil (containing 123.1 mg/kg tyrosol and 233.6 mg/kg hydroxytyrosol) for 26 weeks significantly increases serum ferric reducing antioxidant power (FRAP) by 67.7 μM Fe²⁺ and paraoxonase-1 (PON-1) activity by 3.68 U/mL in elderly individuals (mean age 74) with a prior myocardial infarction, compared to baseline.
Strong evidence
Randomized trialsOne moderate-quality study supports this claim, so treat this as an early signal rather than settled science.
What the research says
1 study reviewedSupporting (1)
Randomized Controlled TrialHuman2025
This study found that elderly people who had a heart attack and drank a specific kind of high-phenol olive oil every day for six months showed better antioxidant markers in their blood, meaning their bodies got better at fighting harmful molecules. This matches exactly what the claim says.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Special compounds in olive oil enter the bloodstream and turn on a cellular switch that makes more antioxidant proteins. These proteins neutralize harmful molecules in the blood and protect an enzyme that prevents fat damage in cholesterol particles, leading to stronger overall antioxidant defense.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In elderly individuals with a prior heart attack, daily consumption of 25 mL of high-phenolic extra virgin olive oil for 26 weeks increases serum antioxidant capacity by 67.7 μM Fe²⁺ and paraoxonase-1 activity by 3.68 U/mL compared to baseline levels.
Mechanism
1 studyCompounds in the olive oil turn on a cellular switch that makes more antioxidant proteins. These proteins clean up harmful molecules in the blood and keep an important protective enzyme working properly, leading to stronger overall antioxidant defense.
Special compounds in olive oil enter the bloodstream and turn on a cellular switch that makes more antioxidant proteins. These proteins neutralize harmful molecules in the blood and protect an enzyme that prevents fat damage in cholesterol particles, leading to stronger overall antioxidant defense.
Hydroxytyrosol and tyrosol are absorbed from the gastrointestinal tract after ingestion of high-phenolic extra virgin olive oil
These compounds activate the PI3K/Akt and ERK1/2 signaling pathways in vascular and immune cells
Activation of these pathways prevents the degradation of the transcription factor Nrf2, allowing it to accumulate and move into the cell nucleus
Nrf2 binds to antioxidant response elements in DNA, increasing the production of antioxidant enzymes including heme oxygenase-1, superoxide dismutase-1, and catalase
The increased levels of antioxidant enzymes enhance the plasma's ability to reduce oxidizing agents, raising ferric reducing antioxidant power (FRAP)
Reduced oxidative stress preserves the structure and function of paraoxonase-1 (PON-1), an enzyme associated with HDL that breaks down oxidized lipids
Preserved PON-1 activity increases its capacity to hydrolyze lipid peroxides in low-density and high-density lipoproteins
Evidence from Studies
Supporting (1)
Community contributions welcome
High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
This study found that elderly people who had a heart attack and drank a specific kind of high-phenol olive oil every day for six months showed better antioxidant markers in their blood, meaning their bodies got better at fighting harmful molecules. This matches exactly what the claim says.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of High-Phenolic Olive Oil Intake on FRAP and PON-1 in Post-MI Elderly Populations
Population: Elderly individuals (mean age ≥70) with prior myocardial infarction; Intervention: 25 mL/day high-phenolic EVOO (123.1 mg/kg tyrosol, 233.6 mg/kg hydroxytyrosol); Comparator: Placebo oil or low-phenolic EVOO; Outcome: Change in serum FRAP (μM Fe²⁺) and PON-1 activity (U/mL); Duration: 26 weeks; Design: Pooling of RCTs with standardized phenolic content and outcome measurement.
Double-Blind Placebo-Controlled Trial of High-Phenolic Olive Oil on Antioxidant Markers in Post-Myocardial Infarction Elderly
Population: 100 elderly individuals (mean age 74) with prior myocardial infarction; Intervention: 25 mL/day high-phenolic EVOO (123.1 mg/kg tyrosol, 233.6 mg/kg hydroxytyrosol); Comparator: Matched low-phenolic olive oil; Outcome: Change in serum FRAP and PON-1 activity from baseline to 26 weeks; Duration: 26 weeks; Design: Randomized, double-blind, parallel-group, with baseline and endpoint biomarker assays.
Prospective Cohort Study of Olive Oil Consumption and Antioxidant Biomarkers in Elderly Post-MI Patients
Population: 500 elderly individuals with prior myocardial infarction; Intervention: Self-reported daily intake of high-phenolic EVOO (≥25 mL/day); Comparator: Low or no intake; Outcome: Serial measurements of FRAP and PON-1 over 26 weeks; Duration: 26 weeks; Design: Prospective cohort with standardized biomarker collection and dietary assessment.
Cross-Sectional Analysis of Olive Oil Intake and Antioxidant Biomarkers in Elderly Post-MI Cohort
Population: 300 elderly individuals with prior myocardial infarction; Intervention: Single-timepoint assessment of olive oil intake (quantity and phenolic content); Outcome: Single-timepoint measurement of serum FRAP and PON-1; Duration: Single visit; Design: Cross-sectional survey with biochemical analysis.
In Vitro Effects of Tyrosol and Hydroxytyrosol on Hepatic PON-1 Expression and FRAP Capacity in Human Hepatocytes
Population: Human hepatocyte cell lines; Intervention: Exposure to tyrosol (123.1 mg/kg equivalent) and hydroxytyrosol (233.6 mg/kg equivalent) at physiologically relevant concentrations; Comparator: Vehicle control; Outcome: Changes in PON-1 enzyme activity and FRAP capacity in cell lysates; Duration: 24–72 hours; Design: Dose-response and time-course experiments with standardized phenolic exposure.